tiprankstipranks
Trending News
More News >
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market

Atrium Therapeutics, Inc. (RNA) Revenue

Compare
5 Followers

Atrium Therapeutics, Inc. Revenue

Atrium Therapeutics, Inc. had a revenue of 860.00K in the quarter ending Dec 31, 2025, with -93.11%. This bring the company's revenue in the last twelve months to 18.75M, Increased -10.13%. In the fiscal year ending Dec 31, 2025, Atrium Therapeutics, Inc. had annual revenue of 18.75M with 72.11% growth.
Revenue (ttm)
18.75M
Revenue Growth
106.27%
P/S Ratio
0.00
Revenue/Employee
$47,967
Employees
391
Market Cap

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
18.75M7.86M+72.11%
Dec 31, 2024
10.90M1.34M+13.99%
Dec 31, 2023
9.56M336.00K+3.64%
Dec 31, 2022
9.22M-102.00K-1.09%
Dec 31, 2021
9.33M2.54M+37.41%
Dec 31, 2020
6.79M4.47M+192.67%
Dec 31, 2019
2.32M1.94M+511.87%
Dec 31, 2018
379.00K